The GREM1-neutralizing antibody–treated group showed a trend toward prolonged overall survival and a trend toward decreased tumor growth, although the groups, as dosed in this study, did not show significant differences in survival ( Supplementary Figure 20E and F ).
← all excerpts
The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
1
—
—